| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.91B | +18.8% |
| Cost of Revenue | $1.03B | +33.7% |
| Gross Profit | $1.88B | +12.1% |
| R&D Expense | $484.2M | -6.4% |
| SG&A Expense | $1.00B | +23.4% |
| Operating Income | $391.2M | +47.2% |
| Interest Expense | $18.6M | -81.5% |
| Pre-tax Income | $390.8M | +124.7% |
| Income Tax | $49.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $642.3M | -39.0% |
| Accounts Receivable | $713.3M | +38.7% |
| Inventory | $306.7M | -14.2% |
| Current Assets | $3.67B | -0.4% |
| Total Assets | $5.39B | +10.9% |
| Current Liabilities | $1.84B | +155.2% |
| Total Liabilities | $3.26B | +24.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $669.5M | +51.3% |
| Capital Expenditures | $364.8M | -6.3% |
| Investing Cash Flow | -$521.5M | -141.3% |
| Financing Cash Flow | -$552.5M | -5412.5% |
| Free Cash Flow | $304.7M | +471.7% |
| +158.3% |
| Net Income | $341.2M | +120.6% |
| EPS (Basic) | $0.88 | -45.0% |
| EPS (Diluted) | $0.82 | -47.1% |
| Stockholders' Equity |
| $2.13B |
| -5.3% |